Thromboxane Receptor Signaling Is Required for Fibronectin-induced Matrix Metalloproteinase 9 Production by Human and Murine Macrophages and Is Attenuated by the Arhgef1 Molecule

被引:14
作者
Hartney, John M. [1 ]
Gustafson, Claire E. [1 ]
Bowler, Russell P. [2 ,3 ]
Pelanda, Roberta [1 ]
Torres, Raul M. [1 ]
机构
[1] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA
[2] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA
[3] Univ Colorado, Sch Med, Denver, CO 80206 USA
基金
美国国家卫生研究院;
关键词
ARACHIDONIC-ACID METABOLISM; NECROSIS-FACTOR-ALPHA; EXTRACELLULAR-MATRIX; PROSTAGLANDIN E-2; HUMAN MONOCYTES; LYSOPHOSPHATIDIC ACID; PROSTANOID RECEPTORS; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-MIGRATION;
D O I
10.1074/jbc.M111.282772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During an inflammatory response, resident and newly recruited tissue macrophages adhere to extracellular matrix and cell-bound integrin ligands. This interaction induces the expression of pro-inflammatory mediators that include matrix metalloproteinases (MMPs). Arhgef1 is an intracellular signaling molecule expressed by myeloid cells that normally attenuates murine macrophage MMP production in vivo and in vitro after cell culture on the extracellular matrix protein, fibronectin. In this study, we have extended the characterization of this fibronectin-induced Arhgef1-regulated signaling pathway in both human and murine myeloid cells. Our results show that MMP9 production by fibronectin-stimulated monocytes and macrophages depends on autocrine thromboxane receptor signaling and that under normal conditions, this signaling pathway is attenuated by Arhgef1. Finally, we show that the expression of ARHGEF1 by human peripheral blood monocytes varies between individuals and inversely correlates with fibronectin-mediated MMP9 production.
引用
收藏
页码:44521 / 44531
页数:11
相关论文
共 65 条
[1]   The Ins and Outs of Leukocyte Integrin Signaling [J].
Abram, Clare L. ;
Lowell, Clifford A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :339-362
[2]  
ALLAN CJ, 1994, J PHARMACOL EXP THER, V270, P446
[3]   G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS [J].
ALTAVILLA, D ;
SQUADRITO, F ;
CANALE, P ;
IOCULANO, M ;
SQUADRITO, G ;
CAMPO, GM ;
SERRANO, M ;
SARDELLA, A ;
URNA, G ;
SPIGNOLI, G ;
CAPUTI, AP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 286 (01) :31-39
[4]   Prostanoid receptors: Subtypes and signaling [J].
Breyer, RM ;
Bagdassarian, CK ;
Myers, SA ;
Breyer, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :661-690
[5]   HUMAN ALVEOLAR MACROPHAGE ARACHIDONIC-ACID METABOLISM [J].
BROWN, GP ;
MONICK, MM ;
HUNNINGHAKE, GW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (06) :C809-C815
[6]  
Caughey GE, 1997, J IMMUNOL, V158, P351
[7]   LPA Receptors: Subtypes and Biological Actions [J].
Choi, Ji Woong ;
Herr, Deron R. ;
Noguchi, Kyoko ;
Yung, Yun C. ;
Lee, Charig-Wook ;
Mutoh, Tetsuji ;
Lin, Mu-En ;
Teo, Siew T. ;
Park, Kristine E. ;
Mosley, Alycia N. ;
Chun, Jerold .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2010, 50 :157-186
[8]   COMPARISON OF THE ACTIONS OF U-46619, A PROSTAGLANDIN H2-ANALOGUE, WITH THOSE OF PROSTAGLANDIN-H2 AND THROMBOXANE-A2 ON SOME ISOLATED SMOOTH-MUSCLE PREPARATIONS [J].
COLEMAN, RA ;
HUMPHREY, PPA ;
KENNEDY, I ;
LEVY, GP ;
LUMLEY, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :773-778
[9]   LAMININ SIKVAV PEPTIDE INDUCTION OF MONOCYTE-MACROPHAGE PROSTAGLANDIN E(2) AND MATRIX METALLOPROTEINASES [J].
CORCORAN, ML ;
KIBBEY, MC ;
KLEINMAN, HK ;
WAHL, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10365-10368
[10]   Regulation of monocyte gene expression by the extracellular matrix and its functional implications [J].
de Fougerolles, AR ;
Koteliansky, VE .
IMMUNOLOGICAL REVIEWS, 2002, 186 :208-220